Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25.
March 15th, 2024 - News Transcripts
March 20th, 2023 - News Transcripts
February 15th, 2022 - Hedge Funds News
June 15th, 2021 - Hedge Funds News
Returns since its inception in May 2014 (through May 20, 2024)